Augmedix Makes Commure Workflow Operator

Buying Augmedix turns Commure from a software vendor into a workflow operator that gets paid every time clinicians need notes completed. Augmedix was already a meaningful business at about $45M of 2023 revenue, so this was not a feature tuck in. It brought a live documentation business, hospital deployments, and a product that sits inside the daily patient visit, which gives Commure one more wedge to sell broader hospital software around it.

• Augmedix sells medical documentation in the most literal sense, it captures the doctor patient conversation and turns it into a chart note for the EHR, using a mix of AI and human review. That means Commure added a service line tied directly to clinician time and note completion, not just another admin tool bought by IT.
  2 sacra 4 augmedix 5 sacra
• The scale was material. Augmedix finished 2023 at roughly $44.9M of revenue and said it exited the year with about $51M in ARR. Against a $139M purchase price, Commure bought a sizable revenue base at roughly 3x trailing revenue, well below the multiples top private AI scribe peers later reached.
  3 sacra 4 augmedix 6 augmedix
• Strategically, documentation is a cross sell bridge into the rest of Commure. If Commure already handles monitoring, billing, or hospital workflow software, the note is the upstream artifact that feeds coding, revenue cycle work, care coordination, and clinician workflow tools. That makes Augmedix additive to both Commure and Athelas products, not separate from them.
  1 sacra 2 sacra 5 sacra

The next step is turning ambient documentation into the front door for a broader hospital operating stack. As Commure pushes Augmedix into large systems like HCA, the note becomes the starting point for downstream coding, billing, and clinical workflow automation, which should make acquired revenue easier to expand into larger multi product contracts over time.